Table of Contents >> Show >> Hide
- What Is Crohn’s Disease, Really?
- The Myth That Crohn’s Only Affects White People
- How Race and Ethnicity Shape the Crohn’s Experience
- Beyond Biology: How Social Determinants and Bias Shape Outcomes
- Building More Inclusive, Equitable Crohn’s Care
- Lived Experiences: How Crohn’s Affects People of All Colors
- Conclusion: Crohn’s Is ColorfulOur Care Should Be Too
Crohn’s disease doesn’t care what shade your skin is, what language you speak at home,
or what music you blast in the car. It’s a chronic inflammatory bowel disease (IBD) that
shows up in every race, ethnicity, and community. For a long time, Crohn’s was treated as
a “white” disease, as if it only happened to light-skinned people with European ancestry.
Today, research and real-life stories are making it very clear: Crohn’s affects all colors.
Understanding that reality is more than just a diversity slogan. It changes how doctors
recognize symptoms, where research dollars go, how insurance policies are written, and
how patients of color get diagnosed and treated. In this article, we’ll unpack what
Crohn’s disease is, how it shows up across different racial and ethnic groups, why
disparities in care exist, and what we can doindividually and collectivelyto make
Crohn’s care more inclusive and equitable.
What Is Crohn’s Disease, Really?
Crohn’s disease is a chronic inflammatory condition that can affect any part of the
digestive tract, from the mouth to the anus, but it most commonly targets the small
intestine and colon. It’s part of the inflammatory bowel disease family, along with
ulcerative colitis. People with Crohn’s often have periods of flare-ups (when symptoms
are active) and remission (when symptoms calm down), but there’s currently no cure.
Common Symptoms of Crohn’s Disease
Symptoms can vary a lot from person to person, but some of the most common include:
- Abdominal pain or cramping (often in the lower right side of the belly)
- Chronic diarrhea, sometimes urgent or with blood
- Unintentional weight loss and poor appetite
- Fatigue and low energy
- Fever or feeling generally unwell
- Delayed growth or puberty in children and teens
Because these symptoms can overlap with other conditionslike infections, irritable
bowel syndrome, or even stressCrohn’s can be tricky to recognize early. That’s a
problem for everyone, but especially for people of color who may already face barriers
to being believed or referred to a specialist in the first place.
How Crohn’s Is Diagnosed
There isn’t a single “Crohn’s test.” Instead, doctors combine information from:
- Blood tests to look for anemia, inflammation, or nutrient deficiencies
- Stool tests to rule out infections and check for inflammation markers
- Endoscopy and colonoscopy to look directly at the digestive tract and take biopsies
- Imaging studies such as CT, MRI, or ultrasound to assess the small intestine and complications
Diagnosis can take time, especially when symptoms are subtle, come and go, or are
dismissed as “just stress” or “something you ate.” For many people of color, the road
to a Crohn’s diagnosis is not just medicalit’s also a story of access, bias, and
systemic inequities.
Treatment Options: Old Standbys and New Kids on the Block
Crohn’s treatment focuses on two big goals: calming inflammation and maintaining long-term
control. Depending on the severity of the disease, doctors may recommend:
- Aminosalicylates (for some mild cases, though less common in Crohn’s than ulcerative colitis)
- Corticosteroids to quickly reduce inflammation during flares
- Immunomodulators that help dial down the immune response over time
- Biologic therapies that target specific inflammatory pathways
- Newer advanced therapies and combinations for moderate to severe disease
- Surgery when complications like strictures, fistulas, or abscesses develop
Many people with Crohn’s also work with dietitians to understand how food affects their
symptoms, manage nutritional deficiencies, and avoid triggers. That’s where cultural and
ethnic background mattersbecause “just cut out spicy food” is not helpful advice if
your family recipes and comfort foods are full of spices, herbs, and traditional ingredients.
The Myth That Crohn’s Only Affects White People
Historically, Crohn’s disease was most often reported in white populations of European
descent, especially in North America and Western Europe. Early research, early clinics,
and early patient groups reflected that bias. Of course, that didn’t mean people of color
weren’t getting Crohn’sit often meant they weren’t being studied, diagnosed, or believed.
Newer research has completely reshaped that picture. Studies in the United States show
that inflammatory bowel diseases, including Crohn’s, are rising in African American,
Hispanic, Asian, and other nonwhite populations. Some data even suggest that incidence
in nonwhite groups has increased at a faster rate than in white populations over recent
decades. In other words, Crohn’s has always been more diverse than the old textbooks
suggested, and it’s getting even more so.
Rising Rates in Communities of Color
Large population studies and national surveys indicate that:
-
While Crohn’s disease may still be most common among white patients overall, cases in
African American, Hispanic, and Asian communities are steadily rising. -
Some cohorts have documented a significant percentage increase in IBD incidence among
nonwhite groups over several decades, even when starting from lower baseline rates. -
In many regions, providers now routinely see Crohn’s in patients of all races and
ethnicities, including multiracial individuals and recent immigrants.
The takeaway: if a person presents with Crohn’s-like symptoms, their skin color should
never be a reason to delay considering IBD. The disease doesn’t check your ethnicity
before it inflames your intestines.
How Race and Ethnicity Shape the Crohn’s Experience
Crohn’s disease biology is complex, and so is the human world it lives in. Genetics, immune
responses, gut bacteria, environment, diet, and smoking all play roles. On top of that,
there are social and structural factors such as racism, income inequality, health insurance
gaps, and healthcare bias. Together, these determine not just who develops Crohn’s, but who
gets diagnosed early, who receives advanced treatment, and who lives with preventable
complications.
Delayed Diagnosis in People of Color
Several studies have found that Black, Hispanic, and other minority patients with IBD are
diagnosed later compared to white patients. That delay may be due to:
-
Lower awareness among both patients and healthcare professionals that
Crohn’s can occur in people of color -
Attributing symptoms to infections, stress, or food intolerance without
considering IBD -
Limited access to gastroenterologists, especially in under-resourced
neighborhoods - Insurance or cost barriers to getting colonoscopies and imaging
By the time some patients of color finally see an IBD specialist, their Crohn’s may be
more severe, with complications that could potentially have been reduced with earlier care.
Different Disease Patterns and Complications
Research suggests that Crohn’s disease can “look” a bit different on average depending on
the racial or ethnic group, even though the core diagnosis is the same. For example:
-
Some studies have reported higher rates of perianal disease (fistulas and abscesses near
the rectum) in Black patients with Crohn’s. -
Certain nonwhite groups appear more likely to have upper gastrointestinal involvement
or penetrating disease, which can lead to complications like strictures or fistulas. -
The need for surgery, hospitalization, or emergency visits can differ among racial and
ethnic groups, often reflecting both biology and access to care.
These differences don’t mean Crohn’s is “a different disease” in people of color. Instead,
they highlight why diverse participation in research and clinical trials matters. If most
trial participants are white, the results may not fully reflect how medications and disease
patterns play out in everyone else.
Access to Care: The Invisible Wall
Living with Crohn’s in the United States can be expensive. Advanced therapies, frequent
lab work, imaging, endoscopies, and specialist visits add up fast. Surveys suggest that a
significant share of people with IBD experience financial hardship just trying to afford
their treatments, and patients of color are more likely to face barriers like:
- Higher rates of being uninsured or underinsured
- Limited access to IBD specialists and comprehensive centers
- Transportation challenges to major medical centers
- Difficulty getting time off work for infusions, procedures, and flares
For some patients, these barriers translate into more emergency-room care and fewer regular
clinic visits, which is the opposite of what you want with a chronic condition. Instead of
manageable, planned care, people end up in crisis-mode care.
Beyond Biology: How Social Determinants and Bias Shape Outcomes
When researchers examine Crohn’s outcomes by race and ethnicity, they often find that
people of color have higher risks of certain complications, surgeries, or hospitalizations.
But when they adjust for factors like income, neighborhood, and insurance, a big part of
the difference can be explained by socioeconomic status and structural inequities.
That doesn’t mean race “doesn’t matter.” It means race and racism shape where people live,
what jobs they hold, what insurance they have, and how they are treated in the healthcare
system. All of that affects Crohn’s care.
What This Looks Like in Real Life
Imagine a few different scenarios:
-
A Black woman with years of “stomach issues” is told it’s anxiety and diet, only to be
diagnosed with Crohn’s after she finally lands a job with good health insurance. -
A Latino construction worker keeps postponing infusions because unpaid time off means
he can’t cover renthis disease flares repeatedly as a result. -
An Asian American college student has chronic diarrhea but avoids talking about it due
to stigma and embarrassment, leading to months of silent suffering before seeking care.
All three technically “have Crohn’s,” but their experiences are shaped by race, culture,
work, family expectations, and access to support. That’s why the simple phrase
“Crohn’s affects all colors” carries so much weight. It reminds us that equity in Crohn’s
care isn’t automaticit has to be built.
Building More Inclusive, Equitable Crohn’s Care
So what does it actually mean to make Crohn’s care fair for everyone, regardless of race
or ethnicity? It’s not just one thingit’s dozens of small and big decisions across
healthcare, research, policy, and community support.
What Healthcare Systems and Policymakers Can Do
-
Invest in IBD centers of excellence in or near diverse communities, not
just in affluent, predominantly white areas. -
Support insurance policies that reduce prior-authorization hurdles for
advanced therapies when medically appropriate. -
Collect and report data on IBD care by race, ethnicity, and income to
identify gaps and track progress. -
Fund outreach and education campaigns that speak directly to Black,
Hispanic, Asian, Native, and multiracial communities.
What Clinicians Can Do
-
Recognize that Crohn’s can and does occur in patients of every race and ethnicityno
one is “too brown” or “too Asian” to have IBD. -
Ask open, nonjudgmental questions about symptoms that might feel embarrassing, like
diarrhea, rectal pain, or fecal urgency. -
Offer culturally sensitive diet counseling that respects traditional foods and
family eating patterns. -
Encourage participation of diverse patients in clinical trials, with clear,
understandable explanations and support.
What Patients and Families Can Do
If you or someone you love is living with Crohn’s disease, you can’t personally fix the
health system (though if you do, please run for office), but you can take steps
to advocate for better care:
- Seek a gastroenterologist who has experience managing IBD.
- Keep a symptom journal to track patterns and triggers.
- Ask questions about treatment options, side effects, and long-term plans.
-
Connect with patient organizations and support groupsespecially those that focus on
people of color living with IBD. - Talk openly (when you feel safe) about your experience. Every story chips away at stigma.
And remember: nothing in this article replaces personal medical advice. Always work with
your healthcare team to make decisions about diagnosis and treatment.
Lived Experiences: How Crohn’s Affects People of All Colors
Statistics are important, but sometimes the best way to understand how Crohn’s affects all
colors is to look at lived experiences. The following are composite stories inspired by
common themes people sharethey’re not real individuals, but they reflect real patterns.
Maya: “I Thought It Was Just Stress”
Maya is a 28-year-old Black woman working in a busy marketing firm. She’s used to
juggling deadlines, family obligations, and the unspoken pressure to be “twice as good.”
When she starts having frequent diarrhea and sharp stomach cramps, she chalks it up to
stress and coffee. Her primary care provider initially agrees, suggesting relaxation and
diet tweaks.
Months later, Maya is exhausted, losing weight, and missing work because she’s afraid of
having an accident on the commute. Finally, she pushes for a referral to a gastroenterologist.
After blood tests, a colonoscopy, and imaging, she hears the words “You have Crohn’s disease.”
It’s a relief to have an answer, but also a shockno one in her world ever talked about IBD.
Once she connects with an IBD center that understands the intersection of race, gender, and
chronic illness, things change. Her care team talks openly about her job demands, her hair-care
routine (because some medications can affect hair), and her fears about being seen as “weak”
if she asks for accommodations at work. She starts a biologic, joins a support group for
Black women with IBD, and slowly builds a version of wellness that includes therapy, faith,
and flare-friendly meal planning.
Carlos: Balancing Work, Family, and Flares
Carlos is a 40-year-old Mexican American father of three who works in construction. He’s tough,
practical, and not thrilled about talking to doctors. When he begins experiencing severe abdominal
pain and weight loss, he keeps going to work anyway. After a particularly bad flare sends him to
the emergency room, he’s hospitalized and finally diagnosed with Crohn’s.
The problem? His treatment plan involves medications that require regular lab monitoring and
infusion appointmentsduring weekday hours, when he’s supposed to be on the job site. If he
misses work, he doesn’t get paid. If he doesn’t get treatment, his symptoms spiral.
With the help of a social worker and a bilingual clinic, Carlos learns about patient assistance
programs, flexible infusion centers, and legal protections for medical leave. He and his care team
also talk through cultural food traditionslike big weekend meals with familyand how to adjust
portion sizes, ingredients, and timing so he can participate without triggering flares. It’s not
perfect, but it’s a step toward living with Crohn’s instead of constantly fighting it.
Aisha: Navigating Stigma and Silence
Aisha is a 19-year-old South Asian American college student. In her family, health issuesespecially
anything involving bowel movementsaren’t exactly dinner-table conversation. When she starts needing
the bathroom six or seven times a day, she feels isolated and ashamed.
At first, she blames dorm food and stress. But when she sees blood in her stool and can’t keep up
in class due to fatigue, she visits the campus health center. The initial workup leads to a referral
to a gastroenterologist, and soon she has a Crohn’s diagnosis.
Aisha worries about how her community will react. Will they see her as “sick” or “fragile”? Will it
affect how relatives view her future marriage prospects? With the help of a culturally aware therapist
and an online support group for Asian IBD patients, she starts reframing the story. She learns to set
boundaries, ask for academic accommodations, and talk about her condition in a way that feels honest
but not defining. Crohn’s is part of her lifebut not the whole story.
Jayden: Growing Up with Crohn’s
Jayden is a 14-year-old multiracial teen who loves basketball and video games. His parents notice
that he’s not growing as quickly as his peers and is constantly tired. He shrugs off stomach pain,
saying, “It’s fine, I’m just tired from practice.” When his pediatrician checks growth charts and
lab work, they notice red flags and refer him to a pediatric GI specialist.
The diagnosis: Crohn’s disease. Jayden is worried he’ll have to quit sports, be “the sick kid,” or
never eat his favorite snacks again. His team reassures him that with the right treatment and nutrition
plan, many kids with Crohn’s still play sports, hang out with friends, and go to college. His care plan
includes medication, growth monitoring, and support for his mental healthbecause being a teen with
chronic illness is a lot, no matter what color you are.
As Jayden’s family meets other parents and kids from different backgrounds at an IBD education day,
something becomes clear: the faces of Crohn’s are every shade. Some families speak English at home;
others speak Spanish, Vietnamese, or Arabic. Some are dealing with costly co-pays; others are trying
to understand complicated insurance paperwork. But they’re all united in wanting their kids to grow up
healthy and hopeful.
Conclusion: Crohn’s Is ColorfulOur Care Should Be Too
“Crohn’s affects all colors” isn’t just a catchy title. It’s a reminder that this disease crosses
racial, ethnic, and cultural linesand so must our compassion, our research, and our healthcare
systems. People of color with Crohn’s are not rare exceptions; they are a vital, visible part of
the IBD community.
When we challenge old myths, measure and confront disparities, and design care that respects culture
and context, everyone benefits. White patients get better, more inclusive systems. Patients of color
get earlier diagnoses, more appropriate treatment, and less gaslighting. Clinicians become better
listeners and learners. Policymakers get clearer data on where to invest.
Crohn’s doesn’t choose its patients by skin tone. It’s on usproviders, patients, families, and
advocatesto make sure our care, research, and support don’t discriminate either.
